down arrow

Sudeep Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
655.55
-4.75 (-0.72%)
BSENSE

Dec 18

BSE+NSE Vol: 1.93 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Sudeep Pharma will declare its result soon on 19 Dec 2025
stock-summaryPrice Point
High/Low

1Day

645.00669.55

52 Week

632.10795.80
Valuation
Technical
Day's Volume

CASH

1.93 lacs (12.98%) Volume

Shareholding (Nov 2025)

FII

1.54%

Held by 65 FIIs

DII

10.92%

Held by 16 DIIs

Promoter

76.15%

When is the next results date for Sudeep Pharma?

17-Dec-2025

The next results date for Sudeep Pharma is 19 December 2025.

The next results date for Sudeep Pharma is scheduled for 19 December 2025.

Read More

Which are the latest news on Sudeep Pharma?

17-Dec-2025
No latest news for Sudeep Pharma found.

Why is Sudeep Pharma falling/rising?

18-Dec-2025

As of 17-Dec, Sudeep Pharma Ltd's stock price is at 656.20, down 1.18% and underperforming against the Sensex. The stock has been in a downward trend for three days, trading below its moving averages, with significantly reduced investor participation and nearing its 52-week low.

As of 17-Dec, Sudeep Pharma Ltd's stock price is falling, currently at 656.20, which reflects a decrease of 7.85 (-1.18%). The stock has underperformed compared to the benchmark Sensex, which has shown a slight increase of 0.20% over the past week, while Sudeep Pharma has declined by 2.96%. Additionally, the stock has been on a consecutive downward trend for the last three days, resulting in a total drop of 6.02% during this period.<BR><BR>The stock is also trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, investor participation has decreased significantly, with delivery volume dropping by 67.35% compared to the 5-day average, suggesting reduced interest from investors. The stock is currently close to its 52-week low, being only 3.67% away from the low of Rs 632.1. These factors collectively contribute to the ongoing decline in Sudeep Pharma's stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 7,404 Cr (Mid Cap)

stock-summary
P/E

77.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

22.26%

stock-summary
Price to Book

17.23

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

When is the next results date for Sudeep Pharma?

The next results date for Sudeep Pharma is scheduled for 19 December 2025....

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

15-Dec-2025 | Source : BSE

This is to inform that the Earnings Call of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and half year ended on September 30 2025 is scheduled on Monday 22nd December 2025 at 11:30 A.M.

Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 And Other Business Items

15-Dec-2025 | Source : BSE

Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/12/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30 2025 and other Business items

Intimation Of Unsecured Loan Granted To Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company

09-Dec-2025 | Source : BSE

Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 as amended we hereby inform you that the Company has granted an unsecured Loan to Sudeep Advanced Materials Private Limited a wholly owned subsidiary (WOS) of the Company.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

19 Dec 2025

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.17
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.30%
ROCE (avg)
28.23%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
77
Industry P/E
34
Price to Book Value
17.23
EV to EBIT
59.07
EV to EBITDA
56.35
EV to Capital Employed
14.88
EV to Sales
20.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
25.18%
ROE (Latest)
22.26%
Technicals key factors
Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Nov 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 15 Schemes (3.44%)

FIIs

Held by 65 FIIs (1.54%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

7.52%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sudeep Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sudeep Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sudeep Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Sudeep Pharma"
  }
]
stock-summaryCompany CV
About Sudeep Pharma Ltd stock-summary
stock-summary
Sudeep Pharma Ltd
Mid Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."